Evidence map›Paper›PMID 40493541›Full record

ArticleVeterinary medicine and science2025

Kinetic of the Maternally-Derived Anti-Parvovirus IgG During the Neonatal Period: A Quantitative Assessment.

Yalda Tamaddon, Mehran Bakhshesh, Farnoush Arfaee, Mohammad Hossein Fallah Mehrabadi, Nader Azadi

Abstract read
In one paragraph

Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yalda TamaddonDepartment of Clinical Sciences, SR. C., Islamic Azad University, Tehran, Iran, Islamic Azad University, Tehran, Iran.
Mehran BakhsheshDepartment of Animal Virology, Razi Vaccine and Serum Research Institute, Research and Diagnosis, Agricultural Research, Education and Organization (AREEO), Karaj, Iran.ORCID 0000-0002-6163-3544
Farnoush ArfaeeDepartment of Clinical Sciences, SR. C., Islamic Azad University, Tehran, Iran, Islamic Azad University, Tehran, Iran.ORCID 0000-0002-0022-5977
Mohammad Hossein Fallah MehrabadiDepartement of Poultry Diseases, Razi Vaccine and Serum Research Institute, Research and Diagnosis, Agricultural Research, Education and Organization (AREEO), Karaj, Iran.
Nader AzadiVeterinary Clinic, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPassive immunity (mainly IgG) protects canine neonates from the highly pathogenic and contagious canine parvovirus, while it can also largely interfere with parvovirus early vaccinations.

objectivesQuantitative evaluation of the anti-parvovirus IgG transferred to newborn puppies from immunised bitches during the neonatal period, as the influence of individual variations on the kinetics of the specific IgG was also estimated.

methodsSera samples from 80 new born puppies were taken at 10 day intervals in a dog kennel and quantitatively assessed for specific anti-parvovirus IgG with a commercial ELISA kit. The resultant data were subjected to specific statistical analysis.

resultsStatistical analysis definitely showed that the anti-parvovirus IgG sufficiently transferred from the vaccinated bitches to their offspring, so that the average titre calculated was 5675.5 and 2625.9 in the 10 and 20 day old puppies, respectively, which were both considered significantly higher than the protective threshold titre (810). In our setting, however, the average anti-parvovirus IgG titre of the one-month old puppies was not significantly estimated protective, 959.7 (median = 15.57) with a coefficient of variation of 148.6%. It was also estimated that factors including bitches' age, litters' diversity, puppies' age, the period from parvovirus vaccination to parturition and litter size reduced the passive anti-parvovirus IgG levels in the newborn puppies, while bitches' parity evaluated as a positive factor to boost passive anti-parvovirus IgG titre.

conclusionsThese results raise our knowledge on the kinetics of passive anti-parvovirus IgG in newborn puppies and are useful for establishing parvovirus vaccination schedules.

Indexed as

Antibodies, ViralDog DiseasesImmunity, Maternally-AcquiredImmunoglobulin GParvoviridae InfectionsParvovirus, CanineAnimalsAnimals, NewbornDogsFemaleKineticsAntibodies, ViralImmunoglobulin Gindividual variationsparvovirus protectionpassive IgGpersistence

Identifiers

PMID40493541
PMCPMC12151208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.